ambamustine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bekesi, JG; Greaves, J; Holland, JF; Roboz, J; Yagi, MJ | 1 |
| Bekesi, JG; Chin, SE; Holland, JF; Scanlon, KJ; Yagi, MJ | 1 |
2 other study(ies) available for ambamustine and Experimental Neoplasms
| Article | Year |
|---|---|
Analytical and pharmacological studies on a new antineoplastic tripeptide, PTT.119.
Topics: Antineoplastic Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Mass Spectrometry; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1985 |
PTT.119, p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl, a new chemotherapeutic agent active against drug-resistant tumor cell lines.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance; Leukemia L1210; Melphalan; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitrogen Mustard Compounds | 1985 |